Foreign Applications. The provisions of the preceding Article will apply to applications for registration of, and maintenance of, the Intellectual Property Rights (excluding copyrights and Know-How) in the Inventions in foreign countries (“Foreign Applications”). NU and the Company shall make the Foreign Applications upon consultation between them. NU shall not use by itself the Intellectual Property Rights in the Inventions resulting from the Joint Research and held solely by NU (“NU Owned Intellectual Property Rights”); provided, however, that NU may use, free-of-charge, the Inventions covered by the NU Owned Intellectual Property Rights for examination, research or educational purposes even after the licensing under Paragraph 3 of this Article or the assignment under Article 15 of this Agreement. If the Company or Company’s appointee notifies NU that it wishes to non-exclusively use the NU Owned Intellectual Property Rights, NU shall grant a non-exclusive license to do so in accordance with a licensing agreement to be executed separately. If the Company or Company’s appointee notifies NU that it wishes to exclusively use the NU Owned Intellectual Property Rights, NU shall grant an exclusive license to do so to the notifying party in accordance with a licensing agreement to be executed separately. If, during and after the second year of the term of the exclusive license pursuant to Paragraph 3 of this Article for certain NU Owned Intellectual Property Rights, the recipient of such license does not use the relevant NU Owned Intellectual Property Rights without any justifiable reason, NU may, upon listening to the opinions of such recipient, grant a license to do so to a party other than the Company or Company’s appointee (the “Third Party”). In such case, the Company shall consent to such licensing. If neither the Company nor Company’s appointee notifies NU that it desires to exclusively use the NU Owned Intellectual Property Rights, NU may, upon listening to the opinion of the Company, grant a license to do so for the relevant NU Owned Intellectual Property Rights to a Third Party.
Foreign Applications. UKRF hereby authorizes LICENSEE, in the name of UKRF or its employees, at LICENSEE's expense, to apply for and seek prompt issuance of, and upon issuance, maintain during the term of this Agreement foreign patent applications and patents as described in the PATENT RIGHTS or as may otherwise apply to the TECHNOLOGY. LICENSEE shall apply all reasonable efforts to retain broad patent claims as are reasonable and practical taking into consideration the need and likelihood of patent issuance and enforceability. UKRF shall take all actions necessary to cooperate with and assist LICENSEE in the filing and prosecution of such patent applications including but not limited to appropriate invention disclosures and execution of documents as requested by LICENSEE's patent counsel. LICENSEE shall keep UKRF informed as to the status of such patent applications including providing UKRF with copies of all written communications with the patent offices, and consulting with UKRF on responses to the patent offices in advance of submission. If LICENSEE fails to diligently pursue any of such patent applications and, within sixty (60) days of UKRF's written request, which shall include submission to LICENSEE of an invention disclosure suitable for implementing the action specified in the request, fails to take such actions set forth in such request respecting the prosecution of any of such patent applications or if LICENSEE abandons any such patent application, UKRF shall have the right, at its expense, to take such actions as are necessary to pursue such patent applications. UKRF shall execute such documents as are reasonably necessary to file with the Patent and Trademark Office notice of LICENSEE's exclusive license under the PATENTS RIGHTS.
Foreign Applications. Princeton shall, at the request of BioNanomatrix, file, prosecute and maintain patent applications and patents covered by Princeton Patent Rights in foreign countries if available. BioNanomatrix consents to the filing of all PCT and foreign patent applications that have already been filed as of the Effective Date. If Princeton desires to file a patent application in any country or countries in which BioNanomatrix has not elected to secure patent rights, Princeton shall notify BioNanomatrix of Princeton’s intention to file such application. BioNanomatrix shall have […***…] from the receipt of such notice to notify Princeton of BioNanomatrix’s desire to have such patent application filed at BioNanomatrix’s expense. If Princeton does not receive notice from BioNanomatrix within such 15-day period, Princeton may file such applications, at Princeton’s sole cost and expense and the resultant patent applications, and resulting patents, shall not be subject to the license agreement.
Foreign Applications. The following patents and patent applications are based upon International Application No. *** filed November 15, 1990 and all are entitled *** .
Foreign Applications. The provisions of the preceding Article shall apply to the registration and maintenance of Intellectual Property Rights (excluding copyrights and Know-How) related to Inventions in foreign countries (“Foreign Applications”).
Foreign Applications. Regarding prosecution and maintenance of foreign patent applications of the Patent Rights, Licensee shall designate in writing that country or those countries, if any, in which Licensee desires such corresponding patent application(s) to be filed. All such applications shall be in University’s name.
Foreign Applications. The following patents and patent applications are based upon International Application No. PCT/US90/06702, filed November 15, 1990 and all are entitled “NON GLYCOSYLATED FGF-4 AND COMPOSITIONS CONTAINING THE SAME”. Australia 68942/91 11/15/90 Issued 2/24/94 Patent No. 642,947 Canada 2,068,871 11/15/90 Pending EPC 91900453 11/15/90 Pending Japan 501065/1991 11/15/90 Pending
